Screener
Bio-Techne TECH CapEx
CapEx at other companies
Other financials
Where this comes from
Reported directly by Bio-Techne in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
The source filing: Bio-Techne’s 10-Q, filed May 6, 2026.
- Filed
- May 6, 2026, 4:31 PM EDT
- Fiscal quarter
- Q3 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-056302
| Line item | Nine Months Ended / March 31, 2026 | Nine Months Ended / March 31, 2025 |
|---|---|---|
| Net cash provided by (used in) operating activities | 196,657 | 189,355 |
| CASH FLOWS FROM INVESTING ACTIVITIES: | ||
| Proceeds from sale of available-for-sale investments | — | 1,085 |
| Additions to property and equipment | (20,370) | (26,116) |
| Distributions from Wilson Wolf | 4,620 | 2,653 |
| Investment in Spear Bio | — | (15,000) |
| Proceeds from sale of assets held-for-sale | 4,617 | 1,789 |
| Net cash provided by (used in) investing activities | (11,133) | (35,589) |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is Bio-Techne's capex?
- Bio-Techne (TECH) reported capex of $9.09M in Q1 2026.
- How has Bio-Techne's capex changed year-over-year?
- Bio-Techne's capex decreased by 10.2% year-over-year, from $10.12M to $9.09M.
- What is the long-term trend for Bio-Techne's capex?
- Over 3 years (2022 to 2025), Bio-Techne's capex has grown at a -11.6% compound annual growth rate (CAGR), from $44.91M to $31.01M.
- What does capex mean?
- Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.
Ask your AI about Bio-Techne's capex.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude